20 June 2013
Keywords: octoplus, presents, locteron, study, results, dutch, company
Article | 28 April 2008
Dutch company OctoPlus has presented positive results for SELECT-1, a Phase IIa trial of its controlled-release chronic hepatitis C treatment
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 April 2008
5 May 2008
19 June 2013
© 2013 thepharmaletter.com